RxDoctor Payments Data

Bethany McQueen

Psychiatric/Mental Health · Melbourne, FLNPI 1083138622

Payments from drug & device makers

$1,417in general payments, 2019–2025

Across 110 payments — averaging $12.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$529
  • Sunovion Pharmaceuticals Inc.$237
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$219
  • Supernus Pharmaceuticals, Inc.$163
  • Otsuka America Pharmaceutical, Inc.$115
  • Alkermes, Inc.$68
  • plus $87 from 3 others

What the payments were for

  • Food & beverage$1,37097%
  • Education$473%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,417 in reported general payments places this provider in the 65th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$45,844
Medicare patients
89
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate12$22,738
VraylarCariprazine Hcl12$18,559
Lurasidone Hcl46$16,654
Aripiprazole86$6,833
Paliperidone ErPaliperidone43$4,197
Duloxetine Hcl60$4,131
Ziprasidone Hcl31$3,040
Desvenlafaxine Succinate ErDesvenlafaxine Succinate99$2,951
Quetiapine Fumarate89$1,839
Divalproex Sodium ErDivalproex Sodium12$1,800
Buspirone Hcl129$1,667
Venlafaxine Hcl ErVenlafaxine Hcl115$1,530
Oxcarbazepine31$1,352
Bupropion XlBupropion Hcl52$1,321
Lamotrigine96$1,094

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$219$22,73812 claims
AbbVieVraylar$529$18,55912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Melbourne

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →